SUSMED, Inc. Hits Day High with Strong 10.5% Intraday Surge

SUSMED, Inc., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a significant uptick in its stock price, gaining 10.5% on March 5, 2026. The stock reached an intraday high of JPY 1,029.00, marking a notable performance against the backdrop of the Japan Nikkei 225, which declined by 1.12% on the same day. Over the past month, SUSMED has shown a positive trend, with a 7.93% increase, outperforming the Nikkei 225's 7.24% gain. Year-to-date, the stock has risen by 20.97%, compared to the Nikkei's 12.88% increase. However, the company's longer-term performance reveals some challenges, with a 3-year decline of 23.86% and a 5-year performance that remains unreported. Despite the recent gains, SUSMED's financial metrics indicate areas of concern, including a low Return on Equity (ROE) of 0.04% and negative EBITDA, suggesting profitability issues. The company's market capitalization stands at JPY 16,109 million, reflecting its small-cap status within the industry.